O-094 Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable Non-small cell lung cancer (NSCLC)

✍ Scribed by Kosmidis, P.; Kalofonos, C.; Syrigos, K.; Skarlos, D.; Fountzilas, G.; Nicolaides, C.; Bafaloukos, D.; Samantas, E.; Bakogiannis, C.; Dimopoulos, A.

• Book ID: 118572642
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 138 KB
• Volume: 49
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(05)80228-4